Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...
This is the fourth and final part of a series that has been published in consecutive weekend editions of the Finger Lakes ...
FOCUS is designed to formalize the Department’s engagement with so-called “data miner” relators who file qui tam complaints under the False Claims Act (FCA). The announcement signals the Department’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results